patient selection for nivolumab in hnscc
Published 7 years ago • 379 plays • Length 4:35Download video MP4
Download video MP3
Similar videos
-
1:31
dr. martins on patient selection for nivolumab in nsclc
-
2:13
nivolumab in hnscc
-
7:36
mrcc patient selection for ipilimumab/nivolumab
-
5:01
patient selection for pembrolizumab in hnscc
-
6:19
nivolumab-related efficacy and toxicity in hnscc patients
-
6:51
pembrolizumab and nivolumab in recurrent hnscc
-
5:56
patient selection in treating hnscc
-
0:40
dr. vokes on selecting nivolumab or pembrolizumab for head and neck cancer treatment
-
1:01
dr. heymach on nivolumab for lung cancer
-
2:07
study results for nivolumab and pembrolizumab in head and neck cancer
-
1:17
dr. ferris on fda approval of nivolumab in patients with head and neck cancer
-
1:15
dr. ferris on significance of checkmate-141 trial for head and neck cancer
-
1:00
dr. ferris on pembrolizumab and nivolumab in head and neck cancer
-
1:36
dr. ferris on potential of nivolumab in head and neck cancer
-
1:58
dr. vokes on nivolumab, pembrolizumab approvals in head and neck cancer
-
0:32
patient selection for ctcl
-
0:39
dr. lopes on the fda approval of nivolumab/ipilimumab in nsclc
-
5:14
immunotherapy for recurrent hnscc
-
3:16
optimizing the use of ipilimumab/nivolumab in mrcc